Enterprise Value

245.6M

Cash

625M

Avg Qtr Burn

-163.3M

Short % of Float

48.06%

Insider Ownership

0.44%

Institutional Own.

61.54%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Update

Phase 3

Data readout

Phase 3

Data readout

RSV Vaccine Details
Respiratory syncytial virus

Phase 3

Update

RSV Vaccine Details
Respiratory syncytial virus

Phase 2

Update

Phase 2

Initiation

RSV Vaccine Details
Respiratory syncytial virus

Phase 1

Update